Tivada Pharmaceuticals disclosed eight insider transactions on March 6, 2026, with executives selling a large amount of stock on March 4 and March 3, respectively. The transaction amounts were significant, indicating active trading behavior by management. The company focuses on biopharmaceuticals and generic drugs.

K-LinePoet

2026-04-16 04:12:48

Abstract generation in progress

On March 6, 2026, Teva Pharmaceutical Industries Limited disclosed eight insider trading transactions. Executive Daniell Richard sold 37.4k shares on March 4, 2026.

【Recent Insider Trades】

Disclosure Date	Position	Name	Trade Date	Buy/Sell	Quantity	Price per Share/USD	Total Amount/USD
March 6, 2026	Executive	Savage Brian	March 4, 2026	Sell	2,675	32.46	$86.8k
March 6, 2026	Executive	Daniell Richard	March 4, 2026	Sell	54k	32.46	$1.75M
March 6, 2026	Executive	Hughes Eric A	March 4, 2026	Sell	11.3k	32.46	$366.1k
March 6, 2026	Executive	Fox Christine	March 4, 2026	Sell	9,098	32.46	$295.4k
March 6, 2026	Executive	Francis Richard D	March 4, 2026	Sell	23.4k	32.46	$759.4k
March 6, 2026	Executive	Daniell Richard	March 4, 2026	Sell	37.4k	32.95	$1.23M
March 5, 2026	Executive	Savage Brian	March 3, 2026	Sell	1,274	32.36	$41.2k
March 5, 2026	Executive	Hughes Eric A	March 3, 2026	Sell	80.8k	32.36	$2.61M
March 5, 2026	Executive	Francis Richard D	March 3, 2026	Sell	442.9k	32.36	$14.33M
March 5, 2026	Executive	Daniell Richard	March 3, 2026	Sell	129k	32.36	$4.17M

【Company Profile】

Teva Pharmaceutical Industries Limited was registered in Israel on February 13, 1944. The company is a global biopharmaceutical company with significant generic drug operations, conducting business in approximately 57 markets worldwide. It focuses on innovation in neuroscience and immunology, while also offering complex generics, biosimilars, and pharmacy brands to meet patient needs.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

Reward
like
Comment
Repost
Share

Comment

Add a comment

No comments

Trending Topics
View More
#
GatePreIPOsLaunchesWithSpaceX
157.15K Popularity
#
Gate13thAnniversaryLive
425.35K Popularity
#
US-IranTalksVSTroopBuildup
774.84K Popularity
#
CryptoMarketRecovery
98.31K Popularity
#
WCTCTradingChallengeShare8MUSDT
626.95K Popularity

Sitemap

U.S. Stock Insider Trading | Tiva Pharmaceuticals disclosed 8 insider trading transactions on March 6

Trending Topics

GatePreIPOsLaunchesWithSpaceX

Gate13thAnniversaryLive

US-IranTalksVSTroopBuildup

CryptoMarketRecovery

WCTCTradingChallengeShare8MUSDT

Pin